Minor
Established
설명
Losartan + hydrochlorothiazide is a guideline-recommended combination for hypertension; the primary interactions are additive hypotension and variable electrolyte effects.
기전
HCTZ promotes sodium and potassium loss and activates RAAS; losartan's AT1 blockade opposes angiotensin II–mediated vasoconstriction and partially retains potassium. Together they have additive blood pressure–lowering effects.
임상적 중요성
Electrolyte monitoring is important: HCTZ promotes hypokalemia, hyponatremia, and hyperuricemia; losartan partially offsets the hypokalemia but hyperuricemia concern is reduced by losartan's uricosuric effect.
관리 방법
Monitor electrolytes and renal function at 4–6 weeks; fixed-dose combination products are widely available and well-studied.